StockData
Veru Inc. logo

Veru Inc. (VERU) stock

VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30
$2.08−0.01 (-0.48%)

Close on Nov 16, 2026Market cap $35.46MP/E –Yield –

Veru EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Veru's EV/EBITDA was 32.1× on Jan 31, 2022, against 7.9× a year earlier. Over the last 5 years it ranged from 4.2× to 199.3×, with a median of 18.2×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 202232.1×−4.3
2021Dec 31, 202136.3×+28.4
2017Jan 31, 20177.9×+0.9
2016Dec 30, 20167.0×+1.7
2015Dec 31, 20155.3×−18.4
2014Dec 31, 201423.7×+1.0
2013Dec 31, 201322.7×+5.2
2012Dec 31, 201217.5×−14.6
2011Dec 30, 201132.1×+0.3
2010Dec 31, 201031.8×+6.0
2009Dec 31, 200925.8×–

More Veru figures

See a number that looks wrong?